Everhart Financial Group, Inc. Bristol Myers Squibb CO Transaction History

Everhart Financial Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$47.98 - $54.4 $207,897 - $235,715	4,333 New	4,333 $234,000
Q2 2023 Jul 13, 2023	BUY	$63.71 - $70.74 $28,796 - $31,974	452 Added 9.56%	5,180 $331,000
Q1 2023 Apr 25, 2023	BUY	$65.71 - $74.53 $3,679 - $4,173	56 Added 1.2%	4,728 $327,000
Q4 2022 Feb 09, 2023	SELL	$68.48 - $81.09 $112,238 - $132,906	-1,639 Reduced 25.97%	4,672 $336,000
Q3 2022 Oct 12, 2022	BUY	$0.13 - $76.84 $43 - $25,818	336 Added 5.62%	6,311 $448,000
Q2 2022 Jul 12, 2022	BUY	$72.62 - $79.98 $209,653 - $230,902	2,887 Added 93.49%	5,975 $460,000
Q1 2022 Apr 18, 2022	BUY	$61.48 - $73.72 $189,850 - $227,647	3,088 New	3,088 $226,000

2,404

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Everhart Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Everhart Financial Group, Inc. with notifications on news.